Invivoscribe® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack® Flex Suite
New ultra-high sensitivity tests enable objective, automation-ready, high-throughput clonality and MRD workflow. SAN DIEGO — Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing (NGS) solution to identify and track immunoglobulin and T-cell…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
